Although ST6GAL1 transcripts levels are lower in breast tumors than in normal adjacent tissues in TCGA breast cancer cohort, however among cancer patients, ST6GAL1 transcripts levels are significantly elevated in triple-negative clinical cases compared with ER+ patients (Fig. 1A, B, and Supplemental Fig. S1A). This evidence concerns the gene ST6GAL1 and breast cancer.